Microbiome Sequencing Services Market Size, Share, Trends, Growth and Forecast 2032

Microbiome Sequencing Services Industry Prospective:

The global microbiome sequencing services market size was worth around USD 1,527 million in 2023 and is predicted to grow to around USD 3,843 million by 2032 with a compound annual growth rate (CAGR) of roughly 10.8% between 2024 and 2032.

Request Free Sample    

Microbiome Sequencing Services Market: Overview

A collection of microorganisms known as microbiomes reside on human bodies. They are present in the lips, saliva, skin, eyes, and digestive system. The human microbiome contains thousands of bacterial species and microorganisms together with their proteins, metabolites, and genes. To learn more about human microbes, microbiome sequencing is the study and examination of microbial communities that are present both within and outside of the human body. The study of the human gut's microbial composition and its consequences for health and disease development is the focus of microbiome sequencing and related methodologies. Finding out a patient's reaction to a certain treatment can be helped by this study. Furthermore, in the early days, the phenotypic or genotypic analysis came after the labor-intensive and time-consuming process of evaluating samples of human skin, stool, or blood. If microbiome sequencing services were better understood and utilized, they would help tailored medicine and diet become more widely available.

Key Insights

• As per the analysis shared by our research analyst, the global microbiome sequencing services market is estimated to grow annually at a CAGR of around 10.8% over the forecast period (2024-2032).
• In terms of revenue, the global microbiome sequencing services market size was valued at around USD 1,527 million in 2023 and is projected to reach USD 3,843 million by 2032.
• The growing gastrointestinal disorder is expected to drive the global microbiome sequencing services market growth over the forecast period.
• Based on the technology, the sequencing by synthesis segment is expected to hold the largest market share during the forecast period.
• Based on the application, the gastrointestinal disorders segment is expected to dominate the market during the forecast period.
• Based on the end user, the pharmaceutical & biotechnology companies segment is expected to hold a significant market share over the forecast period.
• Based on region, North America is expected to dominate the market during the forecast period.

Request Free Sample

Microbiome Sequencing Services Market: Growth Drivers

Increasing legal and quality control requirements drive market growth

The significance of microbiome data in guaranteeing safety and quality standards is being acknowledged by regulatory organizations in the fields of healthcare, agriculture, and food safety. For instance, by identifying possible infections or spoilage organisms, microbiome sequencing is utilized in the food sector to monitor and enhance food safety. Microbiome assessments may also be mandated by agricultural regulatory bodies to guarantee sustainable farming methods. Microbiome sequencing services are required to maintain high-quality standards to comply with these regulations. As a result, businesses and organizations that want to meet regulatory requirements and guarantee the safety of their products have been consistently demanding these services. All of these factors are thus boosting the growth of the microbiome sequencing services market.

Microbiome Sequencing Services Market: Restraints

Microbiome complexity and variability hinder market growth

The complexity and variety of the microbiome itself is a major barrier to the market for microbiome sequencing. The microbiome exhibits great diversity, resulting from a multitude of factors including diet, lifestyle, and environment that influence both individual variances and dynamic changes. Because of this intricacy, standardizing and interpreting results from microbiome sequencing is difficult. The reliability and repeatability of findings can be impacted by inconsistent and discrepant outcomes from microbiome analysis due to a lack of reference databases and standardized methodologies. Furthermore, there is still much to learn about the interpretation and functional implications of microbiome data, which could impede the general acceptance and application of microbiome sequencing in clinical settings. For microbiome sequencing to continue expanding and being widely used, it will be essential to overcome these obstacles and create reliable procedures and standards.

Microbiome Sequencing Services Market: Opportunities

Increasing service launches offer a lucrative opportunity for market growth

The growing services launch in the market offers a lucrative opportunity for microbiome sequencing services industry growth. For instance, in June 2023, with the introduction of its Full-Length 16S Sequencing Service, Zymo Research—a preeminent supplier of tools for microbiology research—offers researchers premium full-length 16S rRNA gene sequencing for microbiome study. Compared to historical, short-read 16S sequencing, the new full-length 16S service offers researchers improved species resolution and data quality at a reasonable price point. Zymo Research is utilizing the most recent sequencing technologies provided by Pacific Biosciences (PacBio) to launch this new service. Numerous sectors and applications have benefited more from this new technology. Full-length 16S will help clinical and academic research benefit from increased precision and cost savings, as well as agricultural and environmental groups with large volume samples.

Microbiome Sequencing Services Market: Challenges

The high cost of services poses a major challenge to market expansion

Due to their high prices, smaller research institutes, academic laboratories, and startups are unable to perform comprehensive microbiome sequencing services. These hefty costs—which include sample collection, DNA extraction, library preparation, and data analysis—make financial challenges for researchers and organizations even worse. Furthermore, impeding the microbiome sequencing services market size is the intricacy of microbiome analysis, which demands advanced sequencing methods and expertise in bioinformatics. These factors also contribute to the overall high cost of these services.

Microbiome Sequencing Services Market: Segmentation

The global microbiome sequencing services industry is segmented based on technology, application, end-user, and region.

Based on the technology, the global microbiome sequencing services market is bifurcated into sequencing by ligation, sequencing by synthesis, sanger sequencing, and others. The sequencing by synthesis segment is expected to hold the largest market share during the forecast period. There has been a lot of interest in researching bacterial populations in the gut, skin, and other organs since sequencing by synthesis (SBS) has a highly parallel structure that allows the simultaneous sequencing of millions of amplicons. Each bacterial community has a unique microbial fingerprint. Segment revenue is predicted to increase because sequencing by synthesis (SBS) is a widely used approach that is employed by multiple commercial companies.

Based on the application, the global microbiome sequencing services industry is bifurcated into cancer, autoimmune disorders, gastrointestinal disorders, and others. The gastrointestinal disorders segment is expected to dominate the market during the forecast period. The trend toward precision and individualized treatment highlights how crucial it is to comprehend the differences in each person's gut microbiome composition. Services for sequencing the microbiome offer important new insights into the role of microbial populations in treatment response, illness susceptibility, and individualized dietary treatments. Microbiome sequencing is also in high demand due to growing research projects and clinical investigations examining the gut-brain axis, gut-immune system interactions, and microbiome-host linkages in gastrointestinal health. The objective of these investigations is to identify novel medicines, therapeutic targets, and biomarkers for gastrointestinal disorders.

Based on the end-user, the global microbiome sequencing services market is bifurcated into pharmaceutical & biotechnology companies, academic research institutes, and others. The pharmaceutical & biotechnology companies segment is expected to hold a significant market share over the forecast period. The significant rise in R&D expenditures and the rise in the number of pharmaceutical and biopharmaceutical patents being issued worldwide are among the factors driving demand for this market.

Microbiome Sequencing Services Market: Report Scope

Microbiome Sequencing Services Market: Regional Analysis

North America region dominates the market over the projected period

During the forecast period, North America is projected to rule the global microbiome sequencing services market. Major key players, such as uBiome, QIAGEN, Thermo Fisher Scientific, and Illumina, are based in the region. To expand their service offerings and market presence, these businesses make significant investments in partnerships, R&D, and acquisitions. Additionally, the area is a center for biomedical research, with major expenditures made in microbiome research by corporate, government, and university institutions. About gastrointestinal illnesses, metabolic issues, and malignancies, among other diseases, this research attempts to investigate the role of the microbiome. Moreover, microbiome sequencing is essential to customized therapy, which is gaining popularity in North America. For example, for gastrointestinal illnesses, personalized treatment strategies based on individual microbiome profiles are becoming increasingly frequent, which is fueling market demand.

Microbiome Sequencing Services Market: Competitive Analysis

The global microbiome sequencing services market is dominated by players like:

• Mérieux NutriSciences Corporation
• Microbiome Insights Inc.
• Clinical-Microbiomics A/S
• Baseclear BV
• Second Genome
• MR DNA
• Zymo Research Corporation
• Metabiomics Corp.
• Rancho BioSciences
• Illumina Inc.
• Thermo Fisher Scientific Inc.
• uBiome Inc.
• Oxford Nanopore Technologies Ltd.
• QIAGEN N.V.
• BGI Genomics Co. Ltd.
• Diversigen Inc.
• Bio-Rad Laboratories Inc.
• Microbiome Therapeutics LLC
• CosmosID Inc.
• Molecular Research LP

The global microbiome sequencing services market is segmented as follows:

By Technology

• Sequencing By Ligation
• Sequencing By Synthesis
• Sanger Sequencing
• Others

By Application

• Cancer
• Autoimmune Disorder
• Gastrointestinal Disorders
• Others

By End User

• Pharmaceutical & Biotechnology Companies
• Academic Research Institutes
• Others

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France 
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa